Information for schools and children's education/care

ASCIA anaphylaxis e-training for schools and children's education/care

www.allergy.org.au/patients/anaphylaxis-e-training-schools-and-childcare 

Adrenaline (epinephrine) injector training devices

ASCIA anaphylaxis e-training courses should always be completed in conjunction with practice using adrenaline (epinephrine) injector training devices (EpiPen® and Anapen®), which do not have a needle and do not contain adrenaline.  To order trainer devices contact:

  • EpiPen - Viatris AU - phone 1800 931 625 or Viatris NZ - phone 0800 168 169
  • Anapen - Allergy Concepts - email This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Pharmacies
  • Patient support organisations - Allergy & Anaphylaxis Australia www.allergyfacts.org.au 
    and Allergy New Zealand www.allergy.org.nz

The supervisor or other adult witness (18 years or older) who signs the certificate to confirm practice with the adrenaline injector trainer devices does not require any special qualifications (except in Victorian state schools - see https://www.allergy.org.au/patients/anaphylaxis-e-training-schools-and-childcare#ad3).  They can refer to instructions on ASCIA Action Plans or videos on the ASCIA website www.allergy.org.au/anaphylaxis 

ASCIA anaphylaxis resources

ASCIA anaphylaxis resources (including action plans, e-training courses and guidelines) are used throughout Australasian schools and children's education/care services. These resources are available at www.allergy.org.au/anaphylaxis  

Anaphylaxis resource hub for schools and children's education/care (CEC) services

https://www.allergyaware.org.au/

This website includes best practice guidelines and risk minimisation strategies for prevention of severe allergic reactions (anaphylaxis) in schools and CEC services:

https://www.allergyaware.org.au/schools/best-practice-guidelines-schools

https://www.allergyaware.org.au/schools/anaphylaxis-risk-minimisation-strategies

https://www.allergyaware.org.au/childrens-education-and-care/best-practice-guidelines-cec 

https://www.allergyaware.org.au/childrens-education-and-care/anaphylaxis-risk-minimisation-strategies

National Allergy Strategy 250K youth project resources

https://nationalallergystrategy.org.au/resources/250k-youth-project

pdfAllergy Aware presentation primary school 20211.20 MB

Allergy Aware presentation primary school 2021

pdfAllergy Aware presentation secondary school 20211.15 MB

Allergy Aware presentation secondary school 2021

Supply update - adrenaline (epinephrine) injectors 

For updated information go to www.allergy.org.au/members/adrenaline-autoinjector-availability 

Patient support organisations

www.allergy.org.au/patients/patient-support-information 

 

Content updated January 2022

Mod ASCIA Member
Donate to AIFA
go to NAC website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

healthdirect